首页> 外国专利> LIVER FIBROSIS INDUCING VECTOR AND METHOD FOR ESTABLISHING ANIMAL MODEL, USING SAME

LIVER FIBROSIS INDUCING VECTOR AND METHOD FOR ESTABLISHING ANIMAL MODEL, USING SAME

机译:使用相同的肝纤维化诱导载体和建立动物模型的方法

摘要

The present invention relates to a liver fibrosis inducing vector and a method for establishing an animal model, using the same. According to the present invention, treatment with tamoxifen at a specific time point allows a Cas9-ERT2 protein complex to translocate from the cytosol into the nucleus. As such, the protein complex that has translocated into the nucleus can more elaborately modify a specific DNA in a desired part at a desired time point with the aid of guide RNA (gRNA). Particularly, application of tamoxifen to a Cas9-ERT2 complex in which a gRNA of the liver fibrosis regulator gene TIF1γ is fused to a hepatic stellate cell-specific promoter knocks out the TIF1γ gene to cause liver fibrosis. TIF1γ is a very important factor in the prevention and treatment of liver fibrosis or liver cirrhosis. Therefore, the present invention can be utilized for developing a technology for analysis of liver fibrosis disease and further is useful for clinical studies such as screening of candidate drugs for treatment of liver fibrosis, with the expectation of finding applications to identifying novel proteins that may be targets of new drug development.
机译:肝纤维化诱导载体和使用该载体的动物模型的建立方法技术领域本发明涉及肝纤维化诱导载体和使用该载体的动物模型的建立方法。根据本发明,在特定时间点用他莫昔芬治疗允许Cas9-ERT2蛋白复合物从胞质溶胶转移到细胞核中。这样,已经转移到细胞核中的蛋白质复合物可以在引导RNA(gRNA)的帮助下,在期望的时间点更精细地修饰特定部分中的特定DNA。特别地,将他莫昔芬应用于其中肝纤维化调节基因TIF1γ的gRNA与肝星状细胞特异性启动子融合的Cas9-ERT2复合体,敲除TIF1γ基因以引起肝纤维化。 TIF1γ是预防和治疗肝纤维化或肝硬化的重要因素。因此,本发明可以用于开发用于分析肝纤维化疾病的技术,并且还可以用于临床研究,例如筛选用于治疗肝纤维化的候选药物,期望找到在鉴定可能是新的蛋白质方面的应用。新药开发的目标。

著录项

  • 公开/公告号WO2018236079A1

    专利类型

  • 公开/公告日2018-12-27

    原文格式PDF

  • 申请/专利权人 SEOUL NATIONAL UNIVERSITY HOSPITAL;

    申请/专利号WO2018KR06451

  • 发明设计人 LEE EUN JU;KIM HYO-SOO;

    申请日2018-06-07

  • 分类号C12N15/85;C12N15/10;C12N15/113;C12N9/22;C07K14/72;A01K67/027;

  • 国家 WO

  • 入库时间 2022-08-21 11:57:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号